You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 14, Issue 12

June-2 2022 - 218 articles

Cover Story: Recently, radiogenomics, a combination of “Radiomics” and “Genomics”, has played a significant role in and offered a new understanding of cancer’s biology and its behavior in response to standard therapies. It also provides a more precise prognosis, investigation, and analysis of a patient’s cancer. Over the years, artificial intelligence (AI) has provided significant strength to radiogenomics. It syndicates large-scale quantifiable data from radiological medical images enveloped with personalized genomic phenotypes and fabricates a prediction model through various AI methods to stratify patients’ risk, monitor therapeutic approaches, and assess clinical outcomes. This review offers the computational and oncological prospects, achievements, and limitations of AI in radiogenomics studies on cancer in the era of precision medicine. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (218)

  • Systematic Review
  • Open Access
13 Citations
3,570 Views
13 Pages

20 June 2022

Diffuse low-grade gliomas (LGG) commonly affect young adults and display a slow evolution, with a life expectancy that can surpass 15 years, thanks to multimodal therapeutic management. Therefore, preservation of quality of life (QoL), including sexu...

  • Systematic Review
  • Open Access
29 Citations
3,275 Views
15 Pages

20 June 2022

The aim of the current study was to evaluate the influence of severe radiation-induced lymphopenia (RIL) on the outcomes of esophageal cancer (EC). A systematic review and meta-analysis was performed through the PRISMA guideline. Seventeen studies we...

  • Article
  • Open Access
2 Citations
3,081 Views
11 Pages

Clinical Outcome of Patients with Pelvic and Retroperitoneal Bone and Soft Tissue Sarcoma: A Retrospective Multicenter Study in Japan

  • Toshiyuki Takemori,
  • Teruya Kawamoto,
  • Hitomi Hara,
  • Naomasa Fukase,
  • Shuichi Fujiwara,
  • Ikuo Fujita,
  • Takuya Fujimoto,
  • Masayuki Morishita,
  • Kazumichi Kitayama and
  • Shunsuke Yahiro
  • + 24 authors

20 June 2022

This study aimed to retrospectively analyze the clinical outcomes of patients with pelvic and retroperitoneal bone and soft tissue sarcoma (BSTS). Overall, 187 patients with BSTS in the pelvis and retroperitoneal region treated at 19 specialized sarc...

  • Feature Paper
  • Article
  • Open Access
10 Citations
3,419 Views
15 Pages

20 June 2022

GI microbiota has been implicated in producing the inflammatory tumor microenvironment of several cancers. Women with ovarian cancer often report GI-related symptoms at diagnosis although minimal is known about the possible GI bacteria that may trigg...

  • Review
  • Open Access
35 Citations
5,783 Views
21 Pages

19 June 2022

BPA, a chemical used in the preparation of polycarbonate plastics, is an endocrine disruptor. Exposure to BPA has been suggested to be a risk factor for breast cancer because of its potential to induce estrogen receptor signaling in breast cancer cel...

  • Article
  • Open Access
3 Citations
2,418 Views
10 Pages

Analysis of the Effect of Tumor-Grade Change on the Prognosis of Retroperitoneal Sarcoma

  • Sung Jun Jo,
  • Kyeong Deok Kim,
  • So Hee Lim,
  • Jinseob Kim,
  • Min Jung Kim,
  • Jae Berm Park and
  • Kyo Won Lee

19 June 2022

In retroperitoneal sarcoma (RPS), the change in the tumor grade from the primary tumor to the first local recurrence, and the effect of this change on prognosis, are unknown. The aim of this study is to analyze whether these changes affect the progno...

  • Review
  • Open Access
11 Citations
5,368 Views
26 Pages

Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives

  • Dominic Kaddu-Mulindwa,
  • Lorenz Thurner,
  • Konstantinos Christofyllakis,
  • Moritz Bewarder and
  • Igor Age Kos

19 June 2022

Extranodal marginal zone lymphoma (EMZL) encompasses a subgroup of non-Hodgkin lymphomas that often present with localized involvement and may manifest in a diversity of organs and tissues. EMZL pathogenesis is in some cases linked to chronic inflamm...

  • Review
  • Open Access
19 Citations
3,859 Views
13 Pages

19 June 2022

Metastases to the thyroid gland arise from other malignant tumors such as renal cell carcinoma, colorectal cancer, lung cancer, and breast cancer. In clinical practice, the incidence is low, and the symptoms are not specific, so it is often missed an...

  • Article
  • Open Access
15 Citations
4,286 Views
12 Pages

The Increasing Role of CT-Guided Cryoablation for the Treatment of Liver Cancer: A Single-Center Report

  • Claudio Pusceddu,
  • Luigi Mascia,
  • Chiara Ninniri,
  • Nicola Ballicu,
  • Stefano Zedda,
  • Luca Melis,
  • Giulia Deiana,
  • Alberto Porcu and
  • Alessandro Fancellu

19 June 2022

Purpose: Cryoablation (CrA) is a minimally invasive treatment that can be used in primary and metastatic liver cancer. The purpose of this study was to assess the effectiveness of CrA in patients with hepatocellular carcinoma (HCC) and liver metastas...

  • Article
  • Open Access
8 Citations
3,859 Views
18 Pages

A Novel Proteogenomic Integration Strategy Expands the Breadth of Neo-Epitope Sources

  • Haitao Xiang,
  • Le Zhang,
  • Fanyu Bu,
  • Xiangyu Guan,
  • Lei Chen,
  • Haibo Zhang,
  • Yuntong Zhao,
  • Huanyi Chen,
  • Weicong Zhang and
  • Yijian Li
  • + 7 authors

19 June 2022

Tumor-specific antigens can activate T cell-based antitumor immune responses and are ideal targets for cancer immunotherapy. However, their identification is still challenging. Although mass spectrometry can directly identify human leukocyte antigen...

of 22

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694